Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idex (IEX) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Idex (IEX) over the last 16 years, with Q3 2025 value amounting to $21.5 million.

  • Idex's Receivables - Other rose 3437.5% to $21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.5 million, marking a year-over-year increase of 3437.5%. This contributed to the annual value of $14.7 million for FY2024, which is 981.6% down from last year.
  • According to the latest figures from Q3 2025, Idex's Receivables - Other is $21.5 million, which was up 3437.5% from $17.4 million recorded in Q2 2025.
  • Idex's 5-year Receivables - Other high stood at $21.5 million for Q3 2025, and its period low was $8.7 million during Q4 2021.
  • Moreover, its 5-year median value for Receivables - Other was $16.8 million (2023), whereas its average is $16.6 million.
  • In the last 5 years, Idex's Receivables - Other plummeted by 2018.35% in 2021 and then surged by 12413.79% in 2022.
  • Idex's Receivables - Other (Quarter) stood at $8.7 million in 2021, then surged by 124.14% to $19.5 million in 2022, then dropped by 16.41% to $16.3 million in 2023, then fell by 9.82% to $14.7 million in 2024, then surged by 46.26% to $21.5 million in 2025.
  • Its Receivables - Other stands at $21.5 million for Q3 2025, versus $17.4 million for Q2 2025 and $17.9 million for Q1 2025.